Peptide and regenerative therapies offer targeted biological support by influencing cellular signaling, tissue repair, metabolic pathways, and neurological function
Ensure vials are tightly capped to prevent air exposure, which can lead to oxidation

Product Specifications Compound: Glutathione (GSH, reduced glutathione) Class: Naturally occurring tripeptide antioxidant Sequence: -Glu-Cys-Gly (-peptide bond) Molecular Formula: CHNOS Molecular Weight: ~307 Da Form: Lyophilized powder Vial Size: 1500mg in 10mL glass vial Purity: 99%+ verified by HPLC and mass spectrometry (See COAs) Research Background Glutathione has been investigated in research literature across several scientific contexts: Cellular redox biology investigations into glutathiones role as the primary intracellular thiol antioxidant and its cycling between reduced (GSH) and oxidized (GSSG) forms Oxidative stress research studies examining cellular response to reactive oxygen species (ROS) and the cellular glutathione systems role in redox homeostasis Thiol biochemistry research analytical chemistry studies on glutathiones sulfhydryl group reactivity and protein S-glutathionylation in cellular research Cellular detoxification pathway research studies on glutathione-S-transferase (GST) enzymatic systems and Phase II metabolism in cellular research models Mitochondrial cellular biology research literature on mitochondrial glutathione pools and their role in cellular bioenergetics research Comparative thiol research analytical studies positioning glutathione alongside other cellular thiol compounds in cellular research contexts Glutathione is one of the most extensively characterized small molecules in cellular biology research, with foundational research spanning over a century of peer-reviewed publications across biochemistry, cellular biology, and analytical chemistry

After 24 weeks, all groups taking retatrutide saw significant weight loss compared to the placebo group (1.6% average weight loss): 7.2% for those taking 1 mg 11.8% for those taking 4 mg after starting with 2 mg 13.9% for those taking 4 mg after starting with 4 mg 16.7% for those taking 8 mg after starting with 2 mg 17.9% for those taking 8 mg after starting with 4 mg 17.5% for those taking 12 mg after starting with 2 mg After 48 weeks, patients taking retatrutide experienced even more substantial losses: 8.7% for those taking 1 mg 16.3% for those taking 4 mg after starting with 2 mg 17.8% for those taking 4 mg after starting with 4 mg 21.7% for those taking 8 mg after starting with 2 mg 23.9% for those taking 8 mg after starting with 4 mg 24.2% for those taking 12 mg after starting with 2 mg The researchers also reported that 100% of patients taking 8 mg or 12 mg saw a weight reduction of at least 5%, and 7583% had a weight reduction of 15% or more

Establishing a sustainable routine that you can maintain for months is more valuable than aggressive short-term protocols